CoM3D is a series of sponsored research programs in PharmE3D lab funded by R&D Research Organisation based in Europe. CoM3D explores the following:
- Continuous manufacturing of pharmaceuticals using state-of-the-art future manufacturing techniques, and
- The development of personalised delivery methods through 3D print technology.
The work programmes continue to expand into key areas of personalised digital health care as well as more urgent areas of work in the current fight against viral pathogens such at Covid-19.
Website: Continuous Manufacturing of Pharmaceuticals and 3D Printed Dosage Forms (CoM3D)
News: CoM3D works to develop patient-focused medicines more efficiently